Barclays’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Barclays's WST Position: Q3 2026 in Review
Barclays reduced its West Pharmaceutical (WST) stake by 17% in Q3 2026, selling an estimated $14.8M and leaving 204,168 shares worth $75.7M. The position accounts for 0.02% of the portfolio, ranked #609.
Barclays first reported a position in WST in Q2 2013 and has held it in 54 quarters since. The position peaked at $88.4M in Q2 2026. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Barclays held 204,168 shares of West Pharmaceutical worth $75.7M as of Q3 2026.
- Barclays sold 42,031 West Pharmaceutical shares in Q3 2026, an estimated $14.8M.
- West Pharmaceutical made up 0.02% of Barclays's portfolio in Q3 2026, its #609 holding.
- Barclays first reported a position in West Pharmaceutical in Q2 2013 and has held it in 54 quarters since.
- Barclays's West Pharmaceutical position peaked at $88.4M in Q2 2026.
- 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.